More than 46 million people in the US met diagnostic criteria for a substance use disorder (SUD) in 2021. These numbers are staggering and suggest that SUD is more common than diabetes in the United States. However, only 6% received treatment. Expanding the care delivery model is essential to improving treatment access and enhancing physical, mental, and social/societal outcomes. Pharmacists can play a key role.
Guest Authors: Melissa C. Palmer, PharmD, BCPS, BCPP and Amanda Stahnke, PharmD, BCACP
Music by Good Talk
Thiazides in Chronic Kidney Disease: New Evidence Challenging Old Dogma
Sequential Additions or Multicomponent Combination? Should Our Approach to Hypertension Be Re-examined?
Extra Protection? Finerenone Use in Patients with Type 2 DM and CKD
Assessing HER Acceptability of Contraception
Preserving hope for patients with Heart Failure with Preserved Ejection Fraction (HFpEF)?
Top Ten Things Every Clinician Should Know about Continuous Glucose Monitors (CGM)
Spice Up Your Sleep Life with Saffron
Will a Dual GIP/GLP-1 Receptor Agonist SURPASS the Crowd?
Cut It Out! Removing EHR Allergy Warnings to Improve Antimicrobial Stewardship
What’s the Right Dose of Aspirin in Patients with Heart Disease?
Bursting the Steroid Bubble: Short-term Use Has Its Consequences
Guiding Antiplatelet Therapy: Is a Personalized Approach Worth It?
Psilocybin for Depression: Is it Worth the Trip?
Up the Creek Without a Paddle? Look to Your Pharmacist to Bridge-It
SGLT2i plus MRAs for Heart Failure: A Sweet or Sour Combination?
Is As-Needed Nasal Corticosteroid Use Needed for Allergic Rhinitis Management?
STEP-ping Up the Game for Weight Management
Raised From The Grave: A Second Life for Sotagliflozin?
Tiny (n-of-1) Trials to Overcome Statin-Associated Muscle Pain
Top Ten Things Every Clinician Should Know About Infographics
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive